Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JXSL0900013	ABF656	albinterferon alfa-2B	Other	Biological Products	Import Drug Application	2009-04-14	Novartis Pharma AG	Novartis Pharma Schweiz AG	Certificate Issued	2010-05-27	view
JXSL0900014	ABF656	albinterferon alfa-2B	Other	Biological Products	Import Drug Application	2009-04-14	Novartis Pharma AG	Novartis Pharma Schweiz AG	Certificate Issued	2011-02-14	view
JXSL1800007	ACZ885	canakinumab	Injection	Biological Products	Import Drug Application	2018-02-22	Novartis Pharma AG	Novartis Pharma Schweiz AG	Certificate Issued	2018-08-27	view
JXSL1800042	ACZ885	canakinumab	Injection	Biological Products	Import Drug Application	2018-10-29	Novartis Pharma AG	Novartis Pharma Schweiz AG	In Review	2018-10-27	view
JXSL1800006	ACZ885	canakinumab	Injection	Biological Products	Import Drug Application	2018-02-22	Novartis Pharma AG	Novartis Pharma Schweiz AG	Certificate Issued	2018-08-27	view
JXSL1800040	ACZ885	canakinumab	Injection	Biological Products	Import Drug Application	2018-10-29	Novartis Pharma AG	Novartis Pharma Schweiz AG	In Review	2018-10-27	view
JXSL1800041	ACZ885	canakinumab	Injection	Biological Products	Import Drug Application	2018-10-26	Novartis Pharma AG	Novartis Pharma Schweiz AG	In Review	2018-10-25	view
JXSL1800043	ACZ885	canakinumab	Injection	Biological Products	Import Drug Application	2018-10-26	Novartis Pharma AG	Novartis Pharma Schweiz AG	In Review	2018-10-25	view
JXHL0800296	AMN107	nilotinib	Active ingredient	Chemical Drugs	Import Drug Application	2008-09-09	Novartis Pharma AG	Novartis Pharma Schweiz AG	Certificate Issued	2009-08-13	view
JXHL0800295	ASA404注射用浓溶液	vadimezan	Injection	Chemical Drugs	Import Drug Application	2008-09-09	Novartis Pharma AG	Novartis Pharma Schweiz AG	Certificate Issued	2009-06-25	view
JXHL0800294	ASA404注射用浓溶液	vadimezan	Injection	Chemical Drugs	Import Drug Application	2008-09-09	Novartis Pharma AG	Novartis Pharma Schweiz AG	Certificate Issued	2009-06-25	view
JXHL0800109	ASA404注射用浓溶液	vadimezan	Injection	Chemical Drugs	Import Drug Application	2008-04-21	Novartis Pharma AG	Novartis Pharma Schweiz AG	Certificate Issued	2009-06-09	view
JXHL1300132	BAF312	siponimod	Other	Chemical Drugs	Import Drug Application	2013-04-18	Novartis Pharma AG	Novartis Pharma Schweiz AG	Certificate Issued	2014-01-09	view
JXHL1400171	BAF312	siponimod	Other	Chemical Drugs	Import Drug Application	2014-06-06	Novartis Pharma AG	Novartis Pharma Schweiz AG	Certificate Issued	2015-10-13	view
JXHL1300131	BAF312	siponimod	Other	Chemical Drugs	Import Drug Application	2013-04-18	Novartis Pharma AG	Novartis Pharma Schweiz AG	Certificate Issued	2014-01-09	view
JXHL1400173	BAF312	siponimod	Other	Chemical Drugs	Import Drug Application	2014-05-30	Novartis Pharma AG	Novartis Pharma Schweiz AG	Certificate Issued	2015-10-13	view
JXHL1300130	BAF312	siponimod	Other	Chemical Drugs	Import Drug Application	2013-04-18	Novartis Pharma AG	Novartis Pharma Schweiz AG	Certificate Issued	2014-01-09	view
JXHL1400172	BAF312	siponimod	Other	Chemical Drugs	Import Drug Application	2014-05-30	Novartis Pharma AG	Novartis Pharma Schweiz AG	Certificate Issued	2015-10-13	view
JXHL1400174	BAF312	siponimod	Other	Chemical Drugs	Import Drug Application	2014-05-30	Novartis Pharma AG	Novartis Pharma Schweiz AG	Certificate Issued	2015-10-13	view
JXHL1300129	BAF312	siponimod	Other	Chemical Drugs	Import Drug Application	2013-04-22	Novartis Pharma AG	Novartis Pharma Schweiz AG	Certificate Issued	2014-01-09	view